These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 19821006)
21. Quantification and detection of DcR3, a decoy receptor in TNFR family. Chen J; Zhang L; Kim S J Immunol Methods; 2004 Feb; 285(1):63-70. PubMed ID: 14871535 [TBL] [Abstract][Full Text] [Related]
22. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196 [TBL] [Abstract][Full Text] [Related]
23. Correlation of tumor necrosis factor alpha levels with disease activity of rheumatoid arthritis. Yen JH; Chen JR; Tsai WJ; Liu HW Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):232-43. PubMed ID: 1342640 [TBL] [Abstract][Full Text] [Related]
24. Decreased levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in sera and synovial fluids of patients with rheumatoid arthritis. Hoffmann JC; Räuker HJ; Krüger H; Bayer B; Zeidler H Clin Exp Rheumatol; 1996; 14(1):23-9. PubMed ID: 8697653 [TBL] [Abstract][Full Text] [Related]
25. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474 [TBL] [Abstract][Full Text] [Related]
26. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Connor JP; Felder M Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214 [TBL] [Abstract][Full Text] [Related]
27. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Lin WW; Hsieh SL Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012 [TBL] [Abstract][Full Text] [Related]
28. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Matsumoto T; Iwasaki K Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid. Kang KY; Lee SH; Jung SM; Park SH; Jung BH; Ju JH J Rheumatol; 2015 Nov; 42(11):2003-11. PubMed ID: 26329338 [TBL] [Abstract][Full Text] [Related]
30. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis. Hasunuma T; Kayagaki N; Asahara H; Motokawa S; Kobata T; Yagita H; Aono H; Sumida T; Okumura K; Nishioka K Arthritis Rheum; 1997 Jan; 40(1):80-6. PubMed ID: 9008603 [TBL] [Abstract][Full Text] [Related]
31. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells. Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616 [TBL] [Abstract][Full Text] [Related]
32. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases. Siakavellas SI; Sfikakis PP; Bamias G Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448 [TBL] [Abstract][Full Text] [Related]
33. Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients. Chen MH; Kan HT; Liu CY; Yu WK; Lee SS; Wang JH; Hsieh SL J Formos Med Assoc; 2017 Jan; 116(1):49-56. PubMed ID: 26911723 [TBL] [Abstract][Full Text] [Related]
34. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Nagatani K; Itoh K; Nakajima K; Kuroki H; Katsuragawa Y; Mochizuki M; Aotsuka S; Mimori A Arthritis Rheum; 2007 Nov; 56(11):3554-63. PubMed ID: 17968879 [TBL] [Abstract][Full Text] [Related]
35. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049 [TBL] [Abstract][Full Text] [Related]
36. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774 [TBL] [Abstract][Full Text] [Related]
37. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome]. Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074 [TBL] [Abstract][Full Text] [Related]
38. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512 [TBL] [Abstract][Full Text] [Related]
39. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. Hsieh SL; Lin WW J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361 [TBL] [Abstract][Full Text] [Related]
40. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]